No abstract available
MeSH terms
-
Adult
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Antigens, CD20 / immunology
-
Antineoplastic Agents, Immunological / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Brain Neoplasms / drug therapy*
-
Brain Neoplasms / immunology
-
Brain Neoplasms / secondary
-
Chemotherapy, Adjuvant / methods
-
Glucocorticoids / therapeutic use
-
Humans
-
Imidazoles / therapeutic use
-
Interferon-beta / therapeutic use
-
Male
-
Melanoma / complications
-
Melanoma / immunology
-
Melanoma / secondary
-
Melanoma / therapy*
-
Multiple Sclerosis / complications
-
Multiple Sclerosis / drug therapy
-
Multiple Sclerosis / immunology*
-
Neoplasm Recurrence, Local / complications
-
Neoplasm Recurrence, Local / immunology
-
Neoplasm Recurrence, Local / therapy*
-
Oximes / therapeutic use
-
Polyethylene Glycols / therapeutic use
-
Pyridones / therapeutic use
-
Pyrimidinones / therapeutic use
-
Skin Neoplasms / complications
-
Skin Neoplasms / immunology
-
Skin Neoplasms / therapy*
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal, Humanized
-
Antigens, CD20
-
Antineoplastic Agents, Immunological
-
Glucocorticoids
-
Imidazoles
-
Oximes
-
Pyridones
-
Pyrimidinones
-
trametinib
-
Polyethylene Glycols
-
Interferon-beta
-
ocrelizumab
-
peginterferon beta-1a
-
dabrafenib